ASVRX | GMNCX | ASVRX / GMNCX | |
Total Expense Ratio | 1.59 | 0.90 | 177% |
Annual Report Gross Expense Ratio | 1.59 | 10.15 | 16% |
Fund Existence | 15 years | 7 years | - |
Gain YTD | -9.665 | -6.709 | 144% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 10000 | 25% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.58B | 14.3M | 32,014% |
Annual Yield % from dividends | 0.54 | 1.00 | 54% |
Returns for 1 year | -9.04 | -5.77 | 157% |
Returns for 3 years | -4.23 | 4.75 | -89% |
Returns for 5 years | 67.39 | 57.07 | 118% |
Returns for 10 years | 5.07 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LADCX | 8.89 | 0.26 | +3.01% |
Lord Abbett Developing Growth C | |||
CCSGX | 24.94 | 0.42 | +1.71% |
Conestoga SMid Cap Institutional | |||
MEMCX | 31.45 | 0.52 | +1.68% |
MFS Emerging Markets Equity C | |||
GVALX | 13.85 | 0.21 | +1.54% |
Gotham Large Value Institutional | |||
FAVAX | 23.24 | 0.31 | +1.35% |
Fidelity Advisor Equity Value A |